Seeing Is Believing
Currently out of the existing stock ratings of Ashwani Verma, 28 are a BUY (68.29%), 10 are a HOLD (24.39%), 3 are a SELL (7.32%).
Analyst Ashwani Verma works at UBS with a stock forecast success ratio of 50.6% fulfilled within 121.21 days on average.
Ashwani Verma’s has documented 82 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 01-Mar-2024.
Analyst best performing recommendations are on TEVA (TEVA PHARMA INDUSTRIES LTD ADR).
The best stock recommendation documented was for ITCI (INTRACELLULAR TH) at 3/29/2023. The price target of $63 was fulfilled within 19 days with a profit of $6.01 (10.55%) receiving and performance score of 5.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
82
$14.3 (21.12%)
82
14 days ago
14/16 (87.5%)
$14.79 (22.01%)
161
Buy
101
$33.3 (49.19%)
101
1 months 27 days ago
14/23 (60.87%)
$30.84 (43.96%)
560
Buy
100
$32.3 (47.71%)
101
1 months 27 days ago
2/10 (20%)
$29.84 (42.53%)
606
Buy
86
$18.3 (27.03%)
86
1 months 27 days ago
12/18 (66.67%)
$15.84 (22.58%)
255
Buy
82
$14.3 (21.12%)
76
2 months 3 days ago
6/8 (75%)
$6.35 (8.39%)
307
Which stock is Ashwani Verma is most bullish on?
Which stock is Ashwani Verma is most reserved on?
What Year was the first public recommendation made by Ashwani Verma?